Skip to main content
. 2020 Aug 17;38(28):3294–3303. doi: 10.1200/JCO.20.00522

TABLE 2.

Summary of TEAEs by Line of Therapy in Patients With GIST Receiving Ripretinib 150 mg Once Daily

graphic file with name JCO.20.00522t2.jpg